Your browser doesn't support javascript.
loading
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Epperla, Narendranath; Zhao, Qiuhong; Chowdhury, Sayan Mullick; Shea, Lauren; Moyo, Tamara K; Reddy, Nishitha; Sheets, Julia; Weiner, David M; Geethakumari, Praveen Ramakrishnan; Kandarpa, Malathi; Bruno, Ximena Jordan; Thomas, Colin; Churnetski, Michael C; Hsu, Andrew; Zurbriggen, Luke; Tan, Xiao-Wei Cherie; Lindsey, Kathryn; Maakaron, Joseph; Caimi, Paolo F; Torka, Pallawi; Bello, Celeste; Ayyappan, Sabarish; Oh, Timothy S; Karmali, Reem; Kim, Seo-Hyun; Kress, Anna; Kothari, Shalin; Sawalha, Yazeed; Christian, Beth; David, Kevin A; Greenwell, Irl Brian; Janakiram, Murali; Kenkre, Vaishalee P; Olszewski, Adam J; Cohen, Jonathon B; Palmisiano, Neil; Umyarova, Elvira; Wilcox, Ryan A; Awan, Farrukh T; Alderuccio, Juan Pablo; Barta, Stefan K; Grover, Natalie S; Ghosh, Nilanjan; Bartlett, Nancy L; Herrera, Alex F; Shouse, Geoffrey.
Afiliação
  • Epperla N; Division of Hematology, The Ohio State University, Columbus, OH.
  • Zhao Q; Division of Hematology, The Ohio State University, Columbus, OH.
  • Chowdhury SM; Division of Hematology, The Ohio State University, Columbus, OH.
  • Shea L; Division of Hematology, Washington University, St. Louis, MO.
  • Moyo TK; Levine Cancer Center, Atrium Health, Charlotte, NC.
  • Reddy N; Vanderbilt University Medical Center, Nashville, TN.
  • Sheets J; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC.
  • Weiner DM; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
  • Kandarpa M; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI.
  • Bruno XJ; Division of Hematology and Oncology, University of Vermont, Burlington, VT.
  • Thomas C; Division of Hematology, Thomas Jefferson University, Philadelphia, PA.
  • Churnetski MC; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA.
  • Hsu A; Division of Hematology, Brown University, Providence, RI.
  • Zurbriggen L; Division of Hematology, University of Wisconsin, Madison, WI.
  • Tan XC; Cancer Institute of New Jersey, New Brunswick, NJ.
  • Lindsey K; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC.
  • Maakaron J; Division of Hematology, University of Minnesota, Minneapolis, MN.
  • Caimi PF; University Hospitals Seidman Cancer Center, Cleveland, OH.
  • Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.
  • Bello C; Division of Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Ayyappan S; Division of Hematology and Oncology, University of Iowa, Iowa City, IA.
  • Oh TS; Division of Hematology, Northwestern University, Chicago, IL.
  • Karmali R; Division of Hematology, Northwestern University, Chicago, IL.
  • Kim SH; Division of Hematology and Oncology, Rush University, Chicago, IL.
  • Kress A; Division of Hematology, Yale University, New Haven, CT.
  • Kothari S; Division of Hematology, Yale University, New Haven, CT.
  • Sawalha Y; Division of Hematology, The Ohio State University, Columbus, OH.
  • Christian B; Division of Hematology, The Ohio State University, Columbus, OH.
  • David KA; Cancer Institute of New Jersey, New Brunswick, NJ.
  • Greenwell IB; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC.
  • Janakiram M; Division of Hematology, University of Minnesota, Minneapolis, MN.
  • Kenkre VP; Division of Hematology, University of Wisconsin, Madison, WI.
  • Olszewski AJ; Division of Hematology, Brown University, Providence, RI.
  • Cohen JB; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA.
  • Palmisiano N; Division of Hematology, Thomas Jefferson University, Philadelphia, PA.
  • Umyarova E; Division of Hematology and Oncology, University of Vermont, Burlington, VT.
  • Wilcox RA; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI.
  • Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
  • Alderuccio JP; Division of Hematology, University of Miami, Miami, FL.
  • Barta SK; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Grover NS; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC.
  • Ghosh N; Levine Cancer Center, Atrium Health, Charlotte, NC.
  • Bartlett NL; Division of Hematology, Washington University, St. Louis, MO.
  • Herrera AF; Division of Hematology, City of Hope, Duarte, CA.
  • Shouse G; Division of Hematology, City of Hope, Duarte, CA.
Blood Adv ; 7(1): 88-91, 2023 01 10.
Article em En | MEDLINE | ID: mdl-36269847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Recidiva Local de Neoplasia Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Recidiva Local de Neoplasia Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article